Asia Pacific: In Asia Pacific, countries such as China, Japan, and South Korea are witnessing a rise in pet ownership and a growing demand for advanced healthcare solutions for animals. China is expected to dominate the market in this region due to its large population of pets.
Europe: The market for monoclonal antibodies in veterinary health in Europe is driven by the presence of well-established veterinary healthcare infrastructure in countries like the United Kingdom, Germany, and France. These countries have high pet ownership rates and a strong focus on research and development in the veterinary sector.